Hypermagnesemia (serum Mg >2.2 mg/dL or >1.1 mmol/L) is an uncommon but potentially life-threatening electrolyte disorder, most often occurring in the setting of renal insufficiency combined with exogenous magnesium intake. [1-2] Symptoms are dose-dependent and progress from loss of deep tendon reflexes to respiratory paralysis and cardiac arrest. [3-4] The clinical hallmark bedside test is loss of the patellar reflex, which signals the onset of magnesium intoxication. [3][5]
1. History
- What magnesium-containing products has the patient been taking? (antacids, laxatives, cathartics, Epsom salts, supplements) [2][6-7]
- Duration, dose, and frequency of magnesium exposure
- Any recent bowel prep or cathartic use (e.g., Epsom salts for colonoscopy prep) [8]
- Onset and progression of weakness, lethargy, nausea, flushing
- Obstetric history: receiving IV magnesium sulfate for preeclampsia/eclampsia? [3][9]
- Renal history: known CKD, dialysis status, recent changes in urine output [10-11]
- GI history: constipation, bowel obstruction, ileus (prolonged colonic retention enhances absorption) [12]
- Any recent ingestion (intentional vs. accidental) [6]
2. Alarm Features
- Loss of deep tendon reflexes (Mg >4 mEq/L / ~4.8 mg/dL) — earliest warning sign [3-4]
- Respiratory depression or apnea (Mg approaching 10 mEq/L / ~12 mg/dL) [3-4]
- Hypotension / refractory bradycardia [2][6]
- Altered mental status / coma [6][13]
- Cardiac arrest — levels >12 mEq/L (~14.6 mg/dL) may be fatal [4]
- Flaccid paralysis [1]
- Hypothermia, circulatory collapse [3]
3. Medications
Causative agents
- Magnesium-containing antacids (Maalox, Mylanta) [2][7]
- Magnesium-containing laxatives/cathartics (magnesium citrate, magnesium hydroxide/Milk of Magnesia, Epsom salts/MgSO₄) [6-7][12]
- IV magnesium sulfate (preeclampsia/eclampsia management, asthma, torsades) [3][9]
- TPN with excessive magnesium [14]
- Magnesium supplements (oral or IV)
Treatment medications
- Calcium gluconate 10% — 10–20 mL IV (1–2 g) as direct antagonist; may repeat [5][15]
- Calcium chloride — alternative, delivers more elemental calcium per volume (use via central line)
- Normal saline — volume expansion to promote renal excretion [6][15]
- Furosemide — loop diuretic to enhance renal magnesium excretion (only if adequate renal function) [6][15]
Contraindicated/caution
- Avoid all magnesium-containing medications in patients with CKD stage 4–5 [7][10]
- Use caution with magnesium in patients with myasthenia gravis — contraindicated per FDA labeling [3]
4. Diet
- In the acute setting, discontinue all oral magnesium-containing products immediately [1]
- Magnesium-rich foods (nuts, seeds, dark chocolate, leafy greens) are rarely a sole cause but should be limited in CKD patients with recurrent hypermagnesemia
- Adequate hydration supports renal magnesium clearance
- Long-term: counsel CKD patients to avoid magnesium-containing OTC products
5. Review of Systems
- Neuro: weakness, lethargy, confusion, drowsiness, areflexia
- Cardiovascular: palpitations, lightheadedness, syncope
- Respiratory: dyspnea, shallow breathing, apnea
- GI: nausea, vomiting, ileus, constipation (may be both cause and effect)
- GU: oliguria/anuria (suggests renal failure as contributing factor)
- Skin: flushing, diaphoresis [3]
6. Collateral History and Family History
- Confirm all OTC medications, supplements, and home remedies with family/caregivers — hypermagnesemia is frequently unsuspected and diagnosed late [2][16]
- Elderly patients living alone may be using excessive cathartics without medical supervision [2]
- Obstetric patients: confirm magnesium infusion rate and duration with nursing/pharmacy
- Family history is generally not contributory (rare exception: familial hypocalciuric hypercalcemia with associated hypermagnesemia from inactivating CaSR mutations) [17]
7. Risk Factors
- Chronic kidney disease (especially CrCl <30 mL/min) — the single most important risk factor [1][10][18]
- Elderly age — often have occult renal impairment and use Mg-containing OTC products [2][16]
- Bowel disorders enhancing absorption: active ulcer disease, gastritis, colitis, bowel obstruction, prior gastrectomy [2][8]
- Obstetric patients receiving therapeutic magnesium [3][9]
- Neonates born to mothers receiving MgSO₄ [5]
- Patients on TPN with incorrect magnesium dosing [14]
- Constipation with prolonged colonic retention of Mg-containing tablets [12]
8. Differential Diagnosis
- Hyperkalemia — similar bradycardia, hypotension, and ECG changes; check K⁺
- Hypocalcemia — may coexist (Mg inhibits PTH secretion); check Ca²⁺ [2]
- Hypothyroidism / myxedema coma — lethargy, hyporeflexia, hypothermia
- Sepsis / septic shock — hypotension, altered mental status (hypermagnesemia can mimic septic shock) [14]
- Botulism — descending flaccid paralysis
- Guillain-Barré syndrome — ascending weakness, areflexia
- Myasthenia gravis crisis — weakness, respiratory failure
- Drug overdose (opioids, benzodiazepines, calcium channel blockers) — respiratory depression, hypotension
- Addisonian crisis — hypotension, weakness
9. Past Medical History
- CKD/ESRD and dialysis status [10-11]
- Prior episodes of hypermagnesemia
- History of constipation and laxative use [12]
- GI surgery (gastrectomy increases absorption risk) [8]
- Preeclampsia/eclampsia history
- Myasthenia gravis (increased susceptibility to Mg toxicity) [3]
- Adrenal insufficiency, hypothyroidism
10. Physical Exam
Vital signs
- Hypotension (vasodilation) [1-2]
- Bradycardia [2][6]
- Hypothermia (in severe cases) [3]
- Respiratory rate: watch for shallow/slow breathing
Focused exam
- Deep tendon reflexes — the most critical bedside assessment; loss of patellar reflex is the earliest clinical sign of toxicity [3][5]
- Muscle tone: diffuse hypotonia, flaccid paralysis
- Mental status: lethargy → obtundation → coma
- Skin: flushing, warmth, diaphoresis [3]
- Respiratory effort: paradoxical breathing, accessory muscle use
- Pupils: may be dilated and sluggish in severe cases
- Abdominal exam: distension, absent bowel sounds (ileus) [1]
11. Lab Studies
- Serum magnesium — confirm the diagnosis (normal 1.7–2.2 mg/dL / 0.7–1.0 mmol/L)
- BMP/CMP — assess renal function (BUN, creatinine), potassium, glucose
- Ionized calcium — frequently low due to Mg-induced PTH suppression; hypocalcemia present in up to 7/8 cases in one series [2]
- Serum phosphorus
- Anion gap — may be low in hypermagnesemia (unmeasured cation) [2]
- ABG/VBG — assess respiratory status and acid-base
- CBC — rule out infection if sepsis is in the differential
- PTH — if hypocalcemia is present
- Urine magnesium / fractional excretion of Mg — helps distinguish renal vs. extrarenal cause
Severity correlation (approximate)
12. Imaging
- Chest X-ray — if respiratory depression or aspiration concern
- Abdominal X-ray / CT abdomen — if oral Mg-containing tablets are suspected to be retained in the GI tract (MgO tablets appear hyperdense on CT) [12]
- Imaging is otherwise not routinely required for the diagnosis of hypermagnesemia
13. Special Tests
- Patellar reflex testing — the single most important bedside screening tool; should be checked serially in patients receiving IV magnesium [3][5]
- Point-of-care iSTAT — rapid ionized Mg and Ca if available
- Continuous pulse oximetry and capnography — monitor for respiratory depression
- No validated scoring systems specific to hypermagnesemia severity exist; management is guided by serum levels and clinical findings
14. ECG
Indications: Obtain ECG in all patients with suspected or confirmed hypermagnesemia. [19]
Expected findings (progressive with rising Mg)
- Prolonged PR interval (first-degree AV block) [3][19-20]
- Widened QRS complex [3][19-20]
- Prolonged QT interval [13][19][21]
- Tall, peaked T waves and prominent U waves [20]
- ST segment elevation (can mimic STEMI) [22]
- High-degree AV block at severely elevated levels [19]
- Bradycardia → asystole / cardiac arrest [3][19]
The AHA recommends continuous ECG monitoring for moderate-to-severe magnesium imbalances. [19]
15. Assessment
Hypermagnesemia is a clinical emergency when symptomatic. It is almost always iatrogenic, resulting from exogenous magnesium administration in the setting of impaired renal clearance. [1-2][18] Key clinical pearls:
- Clinically significant hypermagnesemia is rare in patients with normal renal function, but can occur with massive oral ingestion (e.g., Epsom salts, bowel prep) or in patients with GI conditions enhancing absorption [2][6][8][13]
- The condition is frequently unsuspected — in one case series, hypermagnesemia was not clinically suspected in 6 of 8 patients despite significant sequelae [2]
- Symptoms are dose-dependent and predictable, progressing from hyporeflexia → hypotension → respiratory failure → cardiac arrest [3-4]
- Concomitant hypocalcemia is common and worsens cardiac toxicity [2]
16. Treatment Plan
Immediate stabilization (symptomatic patients)
- Stop all magnesium-containing products immediately [1][15]
- IV calcium gluconate 10%: 10–20 mL (1–2 g) IV over 5–10 minutes — directly antagonizes Mg at the neuromuscular junction and myocardium; may repeat every 5–10 minutes as needed [5][15]
- Airway management — intubate if respiratory depression or apnea [5-6]
- IV normal saline — aggressive volume resuscitation to promote renal excretion [6][15]
Enhanced elimination
- Furosemide 20–40 mg IV — promotes renal Mg excretion (only effective with adequate renal function); maintain euvolemia with concurrent NS [6][15]
- Hemodialysis / CRRT — indicated for severe hypermagnesemia (Mg >6 mg/dL or symptomatic) especially with renal failure or refractory to medical therapy; results in rapid correction [6][8][15]
GI decontamination
- magnesium-free cathartic[12]
Hemodynamic support
- Vasopressors for refractory hypotension
- Transcutaneous/transvenous pacing for symptomatic bradycardia unresponsive to calcium [12]
Mild/asymptomatic hypermagnesemia
17. Disposition
- ICU admission: Mg >6 mg/dL, any hemodynamic instability, respiratory depression, altered mental status, need for dialysis, or cardiac conduction abnormalities [6][16]
- Telemetry/monitored bed: Moderate elevation (Mg 4–6 mg/dL) with intact reflexes and stable vitals
- Observation: Mild asymptomatic elevation with clear reversible cause (e.g., Mg supplement discontinued), normal renal function, and trending down on repeat labs
- Discharge: Only if mild elevation with clear cause removed, normal renal function, asymptomatic, and reliable follow-up
- Nephrology consultation: Renal failure requiring dialysis, severe or refractory hypermagnesemia [6][15-16]
- OB consultation: Pregnant patients on magnesium sulfate infusion with signs of toxicity
18. Follow Up / Return Precautions
- Follow-up: Recheck serum Mg within 24–48 hours after discharge; sooner if CKD
- Return immediately for: recurrent weakness, difficulty breathing, lightheadedness/syncope, confusion, chest pain, palpitations
- Patient counseling:
- Avoid all magnesium-containing OTC products (antacids, laxatives, supplements) unless cleared by a physician
- CKD patients should be educated that "natural" or OTC products can be dangerous [7][10]
- If constipation management is needed, use non-magnesium alternatives (polyethylene glycol, docusate, bisacodyl)
- Expected recovery: With treatment, symptoms typically resolve within hours to days; neurologic function generally recovers fully if treated promptly [6][8]
- Rebound risk: If oral Mg tablets remain in the GI tract, rebound hypermagnesemia can occur even after initial correction — ensure adequate GI decontamination [12]
References
1. Contemporary View of the Clinical Relevance of Magnesium Homeostasis. — Ayuk J, Gittoes NJ. Annals of Clinical Biochemistry. 2014.
2. Unsuspected Morbid Hypermagnesemia in Elderly Patients. — Clark BA, Brown RS. American Journal of Nephrology. 1992.
3. FDA Drug Label. — Updated date: 2026-04-23. Food and Drug Administration.
4. FDA Drug Label. — Updated date: 2021-12-13. Food and Drug Administration.
5. FDA Drug Label. — Updated date: 2026-04-23. Food and Drug Administration.
6. Epsom Salt Ingestion Leading to Severe Hypermagnesemia Necessitating Dialysis. — Walker P, Parnell S, Dillon RC. The Journal of Emergency Medicine. 2020.
7. Magnesium and Drugs Commonly Used in Chronic Kidney Disease. — William JH, Richards K, Danziger J. Advances in Chronic Kidney Disease. 2018.
8. Case Report: Near-Fatal Hypermagnesemia Resulting From the Use of Epsom Salts in a Patient With Normal Renal Function. — Si GF, Ge YX, Lv XP, et al. Frontiers in Medicine. 2024.
9. Inherited and Acquired Disorders of Magnesium Homeostasis. — Wolf MT. Current Opinion in Pediatrics. 2017.
10. Magnesium in Chronic Kidney Disease Stages 3 and 4 and in Dialysis Patients. — Cunningham J, Rodríguez M, Messa P. Clinical Kidney Journal. 2012.
11. Magnesium Balance in Chronic and End-Stage Kidney Disease. — Oliveira B, Cunningham J, Walsh SB. Advances in Chronic Kidney Disease. 2018.
12. Hypermagnesemia in a Constipated Female. — Weng YM, Chen SY, Chen HC, Yu JH, Wang SH. The Journal of Emergency Medicine. 2013.
13. Acute Hypermagnesemia After Laxative Use. — Qureshi T, Melonakos TK. Annals of Emergency Medicine. 1996.
14. Iatrogenic Acute Hypermagnesemia After Total Parenteral Nutrition Infusion Mimicking Septic Shock Syndrome: Two Case Reports. — Ali A, Walentik C, Mantych GJ, et al. Pediatrics. 2003.
15. Endocrine Crises. Hypermagnesemia. — Van Hook JW. Critical Care Clinics. 1991.
16. Magnesium: An Overlooked Electrolyte. — Kala J, Abudayyeh A. The Journal of Emergency Medicine. 2017.
17. Renal Magnesium Handling: New Insights in Understanding Old Problems. — Quamme GA. Kidney International. 1997.
18. Disorders of Calcium and Magnesium Homeostasis. — Agus ZS, Wasserstein A, Goldfarb S. The American Journal of Medicine. 1982.
19. Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association. — Sandau KE, Funk M, Auerbach A, et al. Circulation. 2017.
20. Electrocardiographic Manifestations of Combined Hypercalcemia and Hypermagnesemia. — Mosseri M, Porath A, Ovsyshcher I, Stone D. Journal of Electrocardiology. 1990.
21. Effects of Calcium, Magnesium, and Potassium Concentrations on Ventricular Repolarization in Unselected Individuals. — Noordam R, Young WJ, Salman R, et al. Journal of the American College of Cardiology. 2019.
22. High-Magnesium Exposure to Bullfrog Heart Causes ST Segment Elevation. — Kazama I. The Journal of Veterinary Medical Science. 2021.